Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03373006 · ClinicalTrials.gov registry record · Phase 2
A Phase II Study to Evaluate Axumin PET/CT for Risk Stratification for Prostate Cancer
A Phase 2 study, sponsored by HALO Diagnostics.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT03373006: Completed Phase 2 study, sponsored by HALO Diagnostics.
NCT03373006 is a Phase 2 study that has completed, run by HALO Diagnostics. The registered enrollment target is 20 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03373006, a Phase 2 study, has completed, sponsored by HALO Diagnostics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
To investigate the utility of fluciclovine F 18 for evaluation for metastatic disease in men undergoing laser focal therapy of prostate cancer and the impact on inclusion for a focal therapy cohort.
Primary Outcome
Number of patients with detection of metastasis Secondary Outcome Measure Description: Number of patients with local uptake of Axumin
Interventions
- DRUG Axumin PET/CT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-02-27 |
| Est. Completion | 2020-01-30 |
| Phase | Phase 2 |
What the finished NCT03373006 record still lists
NCT03373006 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 1 intervention - of which Axumin PET/CT is the first listed.
NCT03373006 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03373006 about?
NCT03373006 is a clinical study titled "A Phase II Study to Evaluate Axumin PET/CT for Risk Stratification for Prostate Cancer". To investigate the utility of fluciclovine F 18 for evaluation for metastatic disease in men undergoing laser focal therapy of prostate cancer and the impact on inclusion for a focal therapy cohort.
What is the current status of trial NCT03373006?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2018-02-27. Estimated completion is 2020-01-30.
What interventions are being tested in trial NCT03373006?
The interventions under investigation include: Axumin PET/CT (DRUG).
Who is sponsoring clinical trial NCT03373006?
This trial is sponsored by HALO Diagnostics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03373006's enrollment target sits among peer trials
20 1805th of 2000 higher than 107 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI